Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines

Affiliations

¹ Division of Allergy, Asthma and Pediatric Pulmonology, Department of Pediatrics, Boys Town National Research Hospital, Omaha, Nebraska.
² Division of Infectious Disease and Immunology, Levine Children's Hospital, Atrium Health, Charlotte, North Carolina.
³ Division of Allergy, Department of Medicine, George Washington University School of Health Care Sciences, Washington, District of Columbia.
⁴ Family Allergy and Asthma Care, Flower Mound, Texas.
⁵ Allergy Specialists of Knoxville, Knoxville, Tennessee.
⁶ Division of Allergy, Asthma and Clinical Immunology, Department of Medicine, The University of Mississippi Medical Center, Jackson, Mississippi.
⁷ Division of Infectious Disease and Immunology, Departments of Medicine and Pediatrics, New York University School of Medicine, New York University Langone Health, New York, New York.
⁸ Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia. Electronic address: michael.blaiss@gmail.com.

Kevin R Murphy et al. Ann Allergy Asthma Immunol. 2021 Apr.

. 2021 Apr;126(4):319-320.

doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.

¹ Division of Allergy, Asthma and Pediatric Pulmonology, Department of Pediatrics, Boys Town National Research Hospital, Omaha, Nebraska.
² Division of Infectious Disease and Immunology, Levine Children's Hospital, Atrium Health, Charlotte, North Carolina.
³ Division of Allergy, Department of Medicine, George Washington University School of Health Care Sciences, Washington, District of Columbia.
⁴ Family Allergy and Asthma Care, Flower Mound, Texas.
⁵ Allergy Specialists of Knoxville, Knoxville, Tennessee.
⁶ Division of Allergy, Asthma and Clinical Immunology, Department of Medicine, The University of Mississippi Medical Center, Jackson, Mississippi.
⁷ Division of Infectious Disease and Immunology, Departments of Medicine and Pediatrics, New York University School of Medicine, New York University Langone Health, New York, New York.
⁸ Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia. Electronic address: michael.blaiss@gmail.com.

No abstract available

References

1. McNeil M.M., Weintraub E.S., Duffy J. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016;137(3):868–878. - PMC - PubMed
1. Centers for Disease Control and Prevention COVID-19 Response Team, Food and Drug Administration Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine–United States from December 14-23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(2):46–51. - PMC - PubMed
1. Centers for Disease Control and Prevention Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considera... Available at:
1. Banerji A, Wickner PG, Saff R, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and approach [e-pub ahead of print]. J Allergy Clin Immunol Pract. https://doi.org/10.1016/j.jaip.2020.12.047, accessed January 29, 2021. - DOI - PMC - PubMed
1. Kelso J.M., Greenhawt M.J., Li J.T. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25–43. - PubMed